| Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. | |
| | |
MedLine Citation:
|
PMID: 22197088 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVE: We evaluated the efficacy of fusion imaging, which fuses contrast-enhanced ultrasonography images with arterial-phase, contrast-enhanced CT images as a reference on a single screen in real time, for the evaluation of the effectiveness of radiofrequency ablation for treatment of hypervascular hepatocellular carcinoma. MATERIALS AND METHODS: Eighty hepatocellular carcinoma lesions with a maximum diameter of between 1 and 3cm that were scheduled for treatment with radiofrequency ablation were enrolled in this prospective study. After bolus injection of perflubutane-based contrast agent, fusion imaging combining contrast-enhanced ultrasonography images and arterial-phase, contrast-enhanced CT images was performed one day after radiofrequency ablation. We used two functions, which were subsets of the fusion imaging, to confirm the location of the hepatocellular carcinoma lesions in the ablated areas and to evaluate the presence or absence of an adequate safety margin. Contrast-enhanced CT was performed one month after the ablation. Two blinded observers reviewed the images obtained using both modalities to evaluate the effect of ablation. RESULTS: When the one-month contrast-enhanced CT images were used as the reference standard, the sensitivity, specificity, and accuracy of the one-day fusion imaging for the diagnosis of adequate ablation were 97%, 83%, and 96%, respectively; the kappa value for the agreement between the findings obtained using the two modalities was 0.75. CONCLUSION: Fusion imaging combining contrast-enhanced ultrasonography images and arterial-phase, contrast-enhanced CT images as a reference appears to be a useful method for the early evaluation of the efficacy of radiofrequency ablation for the treatment of hypervascular hepatocellular carcinoma. |
| | |
Authors:
|
Kazushi Numata; Hiroyuki Fukuda; Manabu Morimoto; Masaaki Kondo; Akito Nozaki; Takashi Oshima; Masahiro Okada; Shigeo Takebayashi; Shin Maeda; Katsuaki Tanaka |
Related Documents
:
|
8151478 - Symmetric hypoplasia of the temporal cerebral lobes in an infant with glutaric aciduria... 1553038 - Mri of patients with cerebral palsy and normal ct scan. 11932048 - Prolonged unilateral vasodilatation and brain edema in fulminant hepatic failure, assoc... 19901718 - Transient changes on brain magnetic resonance imaging in a patient with sturge-weber sy... 17170548 - Coronary artery calcifications: a critical assessment of imaging techniques. 2251948 - Intraoperative ultrasound (us) imaging. comparison of pathomorphological findings in us... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-22 |
Journal Detail:
|
Title: European journal of radiology Volume: - ISSN: 1872-7727 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-26 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8106411 Medline TA: Eur J Radiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa 232-0024, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Predicting Chest Wall Pain from Lung Stereotactic Body Radiotherapy for Different Fractionation Sche...
Next Document: Magnesium sulfate as an oral contrast medium in magnetic resonance imaging of the small intestine.